Hepatitis C Services in Waterloo Region
|
|
|
- Lesley Anthony
- 10 years ago
- Views:
Transcription
1 Hepatitis C Services in Waterloo Region A Situational Assessment May 2010 ACCKWA The AIDS Committee of Cambridge, Kitchener, Waterloo & Area Sanguen Health Centre
2 Funding for this report and the Hepatitis C Outreach Practical Support Worker Project provided by the Public Health Agency of Canada. Prepared by: Information and Planning Program, Infectious Diseases, Dental and Sexual Health Division, Region of Waterloo Public Health For more information on this report please contact: Region of Waterloo Public Health 99 Regina Street South Waterloo, Ontario N2J 4V3 (519) For more information on the Hepatitis C Outreach Practical Support Worker Project please contact: The AIDS Committee of Cambridge, Kitchener, Waterloo & Area (ACCKWA) 2B-625 King Street East Kitchener, Ontario N2G 4V4 (519) Sanguen Health Centre 29 Young Street East Waterloo, Ontario N2J 2L4 (519)
3 Table of Contents Executive Summary... 3 Background... 5 Methods... 9 Results Discussion References Appendices #
4 #
5 Executive Summary Hepatitis C is a viral infection carried in the blood caused by the hepatitis C virus (HCV). In Waterloo Region, the most common risk factor for hepatitis C is injection drug use. Other high-risk groups for HCV infection include people who: were formerly incarcerated, spent time in a region where hepatitis C is endemic, received a blood transfusion before 1992, and received healthcare in a country lacking universal precautions. Tattooing or body piercing with nonsterile equipment and needle stick injuries can also cause HCV transmission. The number of new positively screened cases of hepatitis C in Waterloo Region remained relatively stable from with an average of 132 new cases per year, with a corresponding rate of 26.4 per cent per 100,000. The total number of infected individuals is expected to be underrepresented as many at risk (or formerly at risk) for HCV have not been tested. It is therefore imperative that those at risk for hepatitis C be provided with the services and supports required to prevent infection or seek screening, treatment and support for their hepatitis C status. A situational assessment examines the legal and political environment, stakeholders, the health needs of the population, the literature and previous evaluations as well as the overall vision for a certain project or topic area (MOHLTC 2008). This purpose of this study is to complete a situational assessment on hepatitis C services in Waterloo Region. Two methods were used to gather data: individual questionnaires with people infected, affected, and at risk for HCV and focus groups with hepatitis C service providers and healthcare providers. A review of literature was also conducted to provide background to the topic area and support findings. Questionnaires asked about participant demographics, hepatitis C knowledge, risk behaviours, previous testing for hepatitis C, services used in Waterloo Region, difficulties accessing services, and preference for receiving hepatitis C information. Focus group questions related to clients knowledge of hepatitis C, existing hepatitis C services in Waterloo Region, strengths of services, barriers to accessing and providing services, models of care, and opportunities for improving services in Waterloo Region. Frequencies were run for each variable in the questionnaire and cross-tabulations for potentially relevant findings were conducted. Summary themes for each focus group question were also created. A total of 149 questionnaires were completed with persons infected, affected or at risk for hepatitis C. Service and healthcare providers from 12 organizations in Waterloo Region were represented at the focus groups. The majority of questionnaire participants engaged in at least one risk behaviour for hepatitis C. Relating to the use of equipment, 27 per cent indicated they shared needles for injecting drugs, while 58 per cent of the participants had shared pipes and other equipment when smoking or inhaling drugs. Forty-six per cent had received a homemade tattoo or piercing. Focus group participants indicated that few at risk populations are aware of the specific details around transmission and prevention of hepatitis C. This finding was also demonstrated in the questionnaire results which showed that only 16 per cent of participants correctly identified that hepatitis C presented no symptoms in the first few years of infection. Various positive aspects about current hepatitis services available in Waterloo Region were revealed from the situational assessment such as: the availability of clean needles (through the needle exchange program), non-judgemental service provision, anonymous services (prevention, support), outreach services and support services provided through the AIDS Committee of Cambridge Kitchener Waterloo and Area. Notable barriers related to hepatitis C services in Waterloo Region included: transportation to medical appointments (particularly for Cambridge), inadequate prevention, treatment and support services targeting hepatitis C at risk groups, the lack of comprehensive patient management, inadequate knowledge about hepatitis C by some healthcare and service providers, and a lack of coordination or collaboration among existing providers in Waterloo Region. Opportunities to build on current strengths, and mitigate the barriers to service were discussed. These ideas included: a coordinated collaborative strategy for hepatitis C in Waterloo Region, a one-stop shopping clinic for liver treatment services, increased support services for hepatitis C, increased prevention services for hepatitis C, professional development around hepatitis C for service providers, expansion of outreach services, and long-term strategies to address the broader determinants to hepatitis C infection. #
6 #
7 Background Hepatitis C is a viral infection carried in the blood caused by the hepatitis C virus (HCV). Transmission of HCV normally occurs through contact with infected blood. HCV infection causes inflammation in the liver which may progress to a more chronic infection. Over time, chronic hepatitis C infections may lead to cirrhosis (extensive scarring of the liver) and liver failure so that the organ cannot perform its normal functions). Hepatitis C associated cirrhosis is the leading cause for liver transplantation (Health Canada 2009). However, many people who have been infected with hepatitis C do not present with symptoms for decades. Currently, there is no vaccine for hepatitis C. It is therefore imperative that those at high risk for HCV exposure take extra precautions as they may unknowingly spread the infection. Populations at Risk Compared to the human immunodeficiency virus (HIV), HCV is 10 to 15 times more transmissible by blood, and a single injection with a contaminated needle may result in transmission of the infection (Canadian Liver Foundation 2000). Because there currently is no vaccine for HCV, prevention is vital for persons at risk. A risk factor is a behaviour, setting or event that most likely increases the chances of a person to be exposed to and acquire a disease (PHAC 2001). People at risk can be categorized as having high, intermediate, or low risk for hepatitis C (Table 2) (PHAC 2009, Steingart 2008, Region of Waterloo 2006). Table 2: High, intermediate, and low risks associated with HCV exposure High Risk Intermediate Risk Lower Risk People who inject drugs Hemodialysis Patients Mother-to-child transmission Blood transfusion, blood products, or organ transplant before 1992 Tattooing and body piercing (with nonsterile equipment) Higher risk sexual behaviour Incarceration Born, traveled, or resided in a region in which HCV infection is more common Receipt of healthcare in a country where there is a lack of universal precautions Street involved youth High Risk Needle stick injuries Sharing sharp instruments / personal hygiene materials with hepatitis C positive person Healthcare workers and emergency responders In Canada, injection drug use (IDU) is the predominant risk factor for HCV. Persons who inject drugs account for approximately 63 per cent of new HCV infections in Canada each year (PHAC 2007). This is due to the sharing of needles, syringes, spoons, cookers, filters, and other injection equipment that may be contaminated with infected blood. This Canadian finding is echoed in Waterloo Region, where the most commonly known factor for hepatitis C was injection drug use (21 per cent; n = 1537) (Region of Waterloo 2006). It is estimated that there are 41, 000 IDUs in Ontario and approximately 5700 IDUs in Central West (Millson 2004). Of the 5700, it is estimated that 1175 are in Waterloo Region; this is the second highest IDU population in the Central West area (Region of Waterloo 2006). Current prisoners or people who have been formerly incarcerated are also at an increased risk for HCV infection. Risk of infection will range from moderate to high depending on their exposure to shared drug injection materials and tattooing and piercing materials that are potentially contaminated. Also at high risk for hepatitis C are persons who were exposed to contaminated blood, blood products, or organ transplants before 1992 in Canada (prior to the introduction of sensitive blood screening tests). Since the introduction of universal testing in blood and organ donors, the risk infection through contaminated blood products has substantially reduced. #
8 Further, persons who were born, travelled, or resided in a region in which HCV infection is more common may be at high risk for hepatitis C infection. High endemicity of hepatitis C (greater than two per cent of the population) can be found in many countries in Africa, Latin America and Central and South-Eastern Asia. Likewise, persons from a region in which HCV infection is more common are also likely to encounter a healthcare system where there is a lack of universal precautions. For example, persons from less developed countries may receive invasive medical or dental procedures from contaminated equipment that was not properly sterilized. Consequently, new Canadians that have emigrated from other countries are at higher risk for hepatitis C (Health Canada 2009, PHAC 2009, CFPC 2009, Remis 1998, Strathdee 1997). Lastly, street involved youth have been identified as a particularly vulnerable population for HCV infection (Dinner 2005). In a study of seven urban Canadian cities, the Public Health Agency of Canada found that an average of 20 per cent of street youth injected drugs at some point. Rates of HCV infection among the street youth populations in this study averaged four per cent overall, which is well above the prevalence estimated within the general population. Intermediate Risk Hepatitis C is transmitted primarily through large or repeated exposures to infected blood. Hemodialysis is a method for removing waste products or free water from the blood. Long-term hemodialysis patients have frequent but small direct exposures to blood, which places them at a moderate risk for hepatitis C transmission. The risk is especially small in developed countries, such as Canada, where infection control protocols are rigorous. Furthermore, tattooing and body piercing that is done with non-sterile equipment puts people at an intermediate risk for hepatitis C. Likewise, being pricked by a needle or sharp object that has infected blood on it may put one at an intermediate risk for contracting hepatitis C. This may occur in a workplace situation such as a healthcare facility. Moreover, sharing personal hygiene materials such as razors, scissors, nail clippers or a toothbrush with an infected person is also an intermediate risk factor for hepatitis C (Health Canada 2009, PHAC 2009, CFPC 2009). Low Risk During pregnancy, an infected mother may pass hepatitis C to her newborn child (vertical transmission). There is also a very low risk of HCV transmission from mother-to-child through breast milk. Similarly, there is a low risk for HCV transmission in the presence of infected blood via sexual behaviours. For example, persons that have unprotected sex with a hepatitis C positive partner in a non-monogamous relationship or persons that engage in anal sex are at low risk (Health Canada 2009, PHAC 2009, CFPC 2009, PHAC 2001). Burden of Illness in Waterloo Region In 2009, The World Health Organization (WHO) estimated that about 180 million people, approximately 3 per cent of the world s population, were infected with the hepatitis C virus (WHO 2009). In developed countries, such as Canada, disease prevalence is relatively low. Current approximations in Canada estimate that 250,000 people are infected with HCV, corresponding to a prevalence rate of approximately 0.7 per cent of the total population (Health Canada 2009). Given the time between infection and the onset of symptoms of liver damage (often 20 to 30 years), the Public Health Agency of Canada (PHAC) predicts a doubling or tripling of disease conditions related to HCV infection in the future (PHAC 2009). In Ontario, approximately 120,000 people have been infected with HCV (Region of Waterloo 2006). However, this number may underestimate the total number of people infected with HCV as 35 per cent of Canadians who have hepatitis C, do not know they are infected (Region of Waterloo 2006). Individuals who are infected with hepatitis C but who do not experience symptoms are of particular concern as they might not get tested. Without knowing their status they may potentially engage in high risk behaviours and ultimately transmit the infection. In Waterloo Region, the total number of people living with hepatitis C is unknown. However, data is available for the incidence of newly reported cases for Waterloo Region (Table 1, Figure 1). Based on this information, the number of #
9 new positively screened cases of HCV remained relatively stable from with an average of 132 cases per year with a corresponding rate of 26.4 per cent per 100, 000. This number is lower than the average of newly reported cases (n = 169) in Waterloo Region from Waterloo Region s rate is slightly lower than the Ontario average. The total number of infected individuals, and subsequent burden of disease, however is expected to be underrepresented in Waterloo Region. Testing for hepatitis C is generally not part of routine medical care and follow-up. However, testing may be performed when a physician identifies a potential risk for HCV in an individual s history. In Waterloo Region, 77 per cent of cases were identified through physician ordered screening (Region of Waterloo 2006). Testing to diagnose infection as a result of symptoms identified only five per cent of newly reported cases (Region of Waterloo 2006). Table 1: Number and rate of new hepatitis C cases*, Waterloo Region and Ontario, Year Number of new cases Rate per 100,000 Waterloo Region Ontario Waterloo Region Ontario N/A 32.5 N/A , , , , N/A 22.8 N/A *Initial HCV antibody screening tests confirms exposure to HCV and does not indicate active disease. Active disease is confirmed by specialized testing (RNA probe). Figure 1: Rate of new hepatitis C cases, Waterloo Region and Ontario, Rate per 100, Waterloo Region Ontario Year #
10 Hepatitis C Services in Waterloo Region The Hepatitis C Outreach Practical Support Worker Project is an initiative led by the AIDS Committee of Cambridge, Kitchener, Waterloo and Area (ACCKWA) in partnership with Region of Waterloo Public Health (ROWPH). The project is intended to target high risk groups for hepatitis C such as people who inject drugs, sex workers, homeless and precariously housed individuals, street involved youth, immigrant populations from endemic countries, and people who were formerly incarcerated. The project is to provide easily understood, accessible and accurate information regarding hepatitis C transmission, personal health and treatment to persons in high risk groups within a client friendly environment. One component of the project includes a situational assessment led by the Infectious Diseases, Dental and Sexual Health Division of Region of Waterloo Public Health. An environmental scan and gap analysis of community agencies offering services for people infected, affected, or at high risk for hepatitis C is a first step in conducting a situational assessment for Waterloo Region. As a result of the scan, it was found that Waterloo Region has many organizations dedicated to providing a variety of services to persons infected, affected, and at high risk for hepatitis C. Although these services are striving to overcome many challenges, it must be noted that there are gaps in services within the region, as stated in the HCV Strategy Report (Steingart 2008). Firstly, Waterloo Region lacks an organization that oversees all community agencies offering services for people infected, affected, and at risk for hepatitis C. As stated in the HCV Strategy Report 2008, There is no umbrella organization that adequately coordinates access to these services to ensure that [clients] receive proper and timely medical care (Steingart 2008). This gap means that persons with hepatitis C must solely navigate their way through community agencies and a fragmented healthcare system. Secondly, there is a heightened need for improved community awareness and education about hepatitis C. This includes, but is not limited to: increased education on risk factors associated with HCV transmission, the physical effects of hepatitis C, access to community services, and hepatitis C treatment and support options (Steingart 2008). Consequently, increased community awareness will likely reduce the stigma often associated with HCV infection. Moreover, persons infected, affected, and at high risk for hepatitis C were identified by Steingart (2008) to need support to manage their infection. In Waterloo Region, few support groups for people infected with hepatitis C exist. The Hepatitis C Society Kitchener Area Chapter provides monthly meetings and support for people with HCV, however, the group is largely comprised of people who were infected with hepatitis C from blood products prior to 1992 in Canada. The support group is not directed at the community s most marginalized and high risk populations for hepatitis C such as people who inject drugs, sex workers, homeless and precariously housed individuals, street involved youth, immigrant populations, and people who were formerly incarcerated. Lastly, there is a lack of specialized physicians, nurses, and healthcare workers treating patients with hepatitis C in Waterloo Region. The increasing number of people infected with hepatitis C and the decrease in specialized service providers means that many people are not adequately treated. Although there are a handful of gastroenterologists and a physician that treat persons with hepatitis C residing within the region, they cannot provide service to all clients who require care (Steingart 2008). Furthermore, it is often difficult for family physicians to refer clients to a hepatitis C specialist as many organizations do not have an adequate referral system in place. This means that family physicians are merely following clients with HCV but are not referring them to specialists for treatment and management (Steingart 2008). In conclusion, many organizations provide a variety of services for individuals infected, affected and at risk for hepatitis C in Waterloo Region. However, as outlined in the HCV Strategy Report (Steingart 2008), many gaps in services do exist in this region, providing an opportunity to explore strategies to improve hepatitis C services and consequently health outcomes for individuals infected, affected or at risk for hepatitis C. #
11 Methods A situational assessment was conducted to examine future direction for improving hepatitis C services in Waterloo Region. A situational assessment examines the legal and political environment, stakeholders, the health needs of the population, the literature and previous evaluations as well as the overall vision for the project. It encourages considering the strengths of and opportunities for individuals and communities (MOHLTC 2008). The project was managed by Region of Waterloo Public Health and AIDS Committee of Cambridge, Kitchener, Waterloo and Area and funded by the Public Health Agency of Canada (PHAC). Research activities and report development was guided by a steering committee. The Steering Committee represents the intended audience and community partners from Region of Waterloo Public Health, Sanguen Health Centre and ACCKWA. The Steering Committee was involved in the planning, data gathering and report dissemination stages. In addition, two community peer consultants with awareness of local hepatitis C-related services and issues were involved with project development. This study has received research ethics approval from Region of Waterloo Public Health. Data Gathering Two methods were used to gather data: individual questionnaires with people infected, affected, and at risk for HCV and focus groups with service and healthcare providers. A review of literature was also conducted to provide background to the topic area and support any findings. Data gathering tools were developed and approved by the Steering Committee and pilot tested with ten participants (five male and five female) from the target population. Questionnaires: Participants who are infected, affected and at risk for HCV Participants were recruited from all municipalities within Waterloo Region in an attempt to reach a broad spectrum of the target population. Purposeful recruitment occurred at locations where at risk populations may frequent, including: sexually transmitted infection (STI) testing clinics, soup kitchens, homeless shelters, addiction support groups, addiction treatment centres, and community health centres. Individuals invited to complete the questionnaires were: members of one or more of the high risk groups for hepatitis C such as people who inject drugs, sex workers, homeless and precariously housed individuals, street involved youth, immigrant populations from hepatitis C endemic countries, and people who have been formerly incarcerated; members of one or more of the high risk groups for hepatitis C that were aware or were not aware of their current hepatitis C status; 16 years and older; and currently living, or lived within the past year, in Waterloo Region for at least three months. Recruitment activities included: displaying posters in high traffic public areas, service agencies, primary care offices, and community health centres; connecting with individuals through service providers; word of mouth through other participants; and direct outreach from the Hepatitis C Outreach Practical Support Worker at ACCKWA. Participants were also given a monetary incentive for completion of the questionnaire. One individual administered all questionnaires to ensure that participants did not complete more than one questionnaire. #
12 Questions (Appendix A) pertained to participant demographics, hepatitis C knowledge, risk behaviours, previous testing for HCV, services used, difficulties accessing services, and preference for receiving hepatitis C information. Focus Groups: Service/ Healthcare Providers Four focus groups were conducted with invited service and healthcare providers with representation from all municipalities in Waterloo Region. Focus groups were two hours in length with up to six participants in each group. An employee that currently provides a service to individuals that are infected, affected or at risk for hepatitis C was eligible to participate in the focus groups. This includes programs or services intended to prevent or treat HCV or provide support for hepatitis C related issues to persons living in Waterloo Region. Mailed letters and follow-up s and telephone calls were used to recruit for the focus groups. Service and healthcare providers representing the following groups in Waterloo Region were invited to participate: AIDS Committee of Kitchener, Waterloo, Cambridge and Area Ontario Works Cambridge Memorial Hospital Emergency Department Private addiction counsellors Cambridge Shelter - The Bridges Ray of Hope Canadian Mental Health Association Reaching Our Outdoor Friends Conestoga College Health Services Region of Waterloo Police Department Local physicians (gastroenterologists) Region of Waterloo Public Health Grand River Hospital Salvation Army New Directions Grand River Withdrawal Management Sanguen Health Centre House of Friendship St. John s Kitchen Kitchener Downtown Community Health Centre The Working Centre Kitchener-Waterloo Multicultural Centre University of Waterloo Health Services KW Counselling Wilfrid Laurier University Health Services Langs Farm Community Health Centre Woolwich Community Health Centre Ministry of Community Safety and Correctional Services Probation Officers YMCA Newcomers Program Mosaic Counselling YWCA- Mary s Place Ontario Addiction Treatment Centres Kitchener and Cambridge Focus group questions (Appendix B) were related to clients knowledge of hepatitis C, existing hepatitis C services in Waterloo Region, strengths of services, barriers to accessing and providing services, models of care, and opportunities for improving hepatitis C services in Waterloo Region. The same questions were asked at each focus group. One facilitator conducted all focus groups, and one project team member took all notes from each focus group. Data Management and Analysis Results from the questionnaires were entered into an SPSS database. Variables were created for each question on the questionnaire. Frequencies were run for each variable. Cross-tabulations for potentially relevant findings were also conducted. The following cross-tabulations were calculated: City by services used City by difficulties accessing services Been previously tested by risk behaviour Gender by services used Gender by difficulties accessing services Been previously tested by gender Been previously tested by services used Gender by services desired Been previously tested by housing Age by services used City by services desired Been previously tested by city Age by difficulties accessing services Age by services desired Been previously tested by age Gender by risk behaviours Age by risk behaviours City by risk behaviours Been previously tested by difficulties accessing services Focus group responses were captured in Microsoft Word. All responses were listed under each question, and summary themes from the responses were created under each focus group question. #
13 Results A total of 149 questionnaires were completed with persons infected, affected or at risk for hepatitis C. Service and healthcare providers from 12 organizations in Waterloo Region were represented at the focus groups. Population Characteristics A diverse group of individuals infected, affected or at risk for hepatitis C completed the questionnaires (Table 3). Males comprised of a greater proportion compared females (61 per cent vs. 38 per cent). Age composition was proportionate (range, to 60-69), with those aged 30 to 49 representing the majority (64 per cent) of the participants. Most of the participants lived in Kitchener (52 per cent) with 17 per cent residing in Waterloo, and 11 per cent from Cambridge. Three per cent of participants were from one of the rural townships. Many individuals indicated that they lived in their own place (52 per cent), and 30 per cent noted that they were staying in a shelter or did not have a fixed address. The majority of participants were born in Canada (85 per cent). Other countries of birth ranged across the globe (El Salvador, Cuba, Mexico, Nicaragua, United States, United Kingdom, France, Germany, Hungary, Italy, Poland, Portugal, Nigeria, and Zimbabwe). The majority of participants engaged in at least one risk behaviour for hepatitis C. Relating to the use of equipment, 27 per cent indicated they shared needles for injecting drugs, while 58 per cent of the participants shared pipes when smoking drugs or received a homemade tattoo or piercing (46 per cent). Half (51 per cent) have previously been incarcerated, while 60 per cent have lived on the street. Relatively few questionnaire participants have had sex for money or drugs (17 per cent), had a blood transfusion before 1992 in Canada (15 per cent), or received medical care outside of North America (11 per cent). Approximately half (52 per cent) of the participants had indicated that have been previously tested for hepatitis C. Table 3: Demographics, risk behaviour of questionnaire participants Per cent of Questionnaire Variable Participants Gender Male 61 Female 38 Age City Kitchener 52 Waterloo 17 Cambridge 11 Townships 3 Housing Own place 52 Shelter 15 No fixed address (streets) 15 Staying with friends/family 9 #
14 Per cent of Questionnaire Variable Participants Hospital 1 Born in Canada 85 Previously tested for hepatitis C Yes 52 No 44 Risk Factor Shared needles and supplies for injecting drugs 27 Shared pipes when smoking drugs 58 Had sex for money or drugs 17 Been in jail 51 Lived on the street 60 Gotten a homemade tattoo / piercing 46 Blood transfusion before 1992 in Canada 15 Received medical care outside North America 11 Knowledge about hepatitis C transmission by individuals infected, affected or at risk for hepatitis C was assessed using the individual questionnaires, and during discussion at the focus groups. Table 4 provides a summary of the results. The majority of participants indicated correctly that hepatitis C is an infection of the liver (61 per cent). Most also correctly identified how hepatitis C can be transmitted (range, 62 per cent to 87 per cent). Of interest is the finding that only 16 per cent of respondents correctly selected no symptoms as the main sign or symptom of hepatitis C. The results from the questionnaires are echoed by the comments from service and healthcare providers during the focus groups. Providers identified that some sub-groups of populations understand hepatitis C well. Those that have been previously counselled, were HCV-positive, were formerly incarcerated (where they may have received education), and those who knew peers with HCV were stated as knowing about hepatitis C. Providers indicated that few at risk populations were aware of the more specific details around transmission and prevention of hepatitis C. In particular, they stated that youth do not have much knowledge about hepatitis C and that prevention efforts should target younger generations. Providers did indicate, however, that knowledge about prevention of hepatitis C was greater than knowledge about transmission. They elaborated that prevention efforts are similar to those of other infectious diseases (such as HIV) and that many individuals find it easier to prevent everything together. Providers stressed that irregardless of the level of knowledge about prevention or transmission of hepatitis C, pertaining to injection drug users in particular, there are obstacles to behaviour change. Focus group participants indicated that at risk populations need to care about the issue to be able to change their risk behaviour. It was also noted that many factors beyond knowledge about hepatitis C influence one s decision to improve their behaviour. These factors include housing status, addiction, mental health and other broader determinants. As stated by one provider, they are overwhelmed by the day to day survival issues and do not think long-term. Table 4: Knowledge about hepatitis C among at risk populations in Waterloo Region Questionnaire Results Per cent of participants with correct answer Question Correct answer What is hepatitis C?* Infection of the liver 61 How can you get hepatitis C?* Blood to blood 87 Tattoos 56 Sharing razors and toothbrushes 62 What are some of the signs and symptoms of hepatitis C infection?* There are no symptoms 16 #
15 Focus Group Results Some sub-groups of people understand well. "Those aware of positive status; those that have been counselled; formerly incarcerated (educated in jail); healthcare providers; those who have friends with hepatitis C." Most at risk populations do not understand well. "There is not much middle ground. People who have been diagnosed are knowledgeable, most at risk do not know very much; Not well at all - at all ages have no idea." At risk youth do not have knowledge about Hepatitis C. "The youth are not as well educated as the older drug users; Prevention efforts should focus on youth. Knowledge about prevention is greater compared to knowledge about transmission of hepatitis C. "Most people take the same precautions to prevent HIV; Many find it easier to remember how to prevent everything together." Knowledge does not lead to behaviour change. "If they don't care, whether they understand is not relevant; they understand but getting high seems more important; knowledge is not the barrier; even if they understand, they take the risk to get their drug fix; there are blocks to behaviour change such as addiction, not valuing health, not seeing immediate harm; they are overwhelmed by day to day survival issues and do not think long-term." * Participants were given a choice of multiple answers The majority of cross-tabulations did not disclose any notable findings. It was revealed however, that those that have been tested for hepatitis C have used more services in the community (ROWPH, internet, family doctor, friends/family, support group, outreach services, community agencies, and healthcare centres). Not surprisingly, those that have not been tested indicated that they did not access any hepatitis C services in Waterloo Region (74 per cent of those that have not been tested did not use any services for hepatitis C information). Cross-tabulations also revealed that 55 per cent of questionnaire participants residing in Kitchener or Waterloo have been tested for hepatitis C. In comparison, only 38 per cent of participants living in Cambridge have been tested. Strengths of Hepatitis C Services in Waterloo Region Questions related to existing hepatitis C services in Waterloo Region were asked in the questionnaires and during the focus groups. Table 5 summarizes the questionnaire results related to hepatitis C services. Half of the questionnaire respondents indicated that they used the services of Region of Waterloo Public Health (56 per cent) or a family doctor (51 per cent) for information about hepatitis C. Over one-third of respondents also indicated using a healthcare centre or hospital (44 per cent), an outreach worker (37 per cent), the internet (36 per cent), family/friends (34 per cent) or community agencies (34 per cent) for hepatitis C information. Finally, 16 per cent of respondents did not access any services for information. Focus group participants identified various positive aspects about current hepatitis services available in Waterloo Region. A summary of focus group results is presented in Table 6. Providers indicated that current harm reduction services where available, are well received and working well. They specified that the needle exchange program in particular is effective and should be expanded. Current services provided through Sanguen Health Centre and ACCKWA were identified as strengths in Waterloo Region by focus group participants. Sanguen Health Centre specializes in Hepatitis B and C treatment, with Dr. Chris Steingart as the primary physician along with his healthcare provider team treating clients. ACCKWA is a non-governmental organization whose mandate is to provide prevention, education, advocacy and support programs/services to those infected, affected or at risk for HIV. Aspects about hepatitis C-related services that were praised include: providing a welcoming, non-judgemental and homey atmosphere, having knowledgeable, friendly providers, and the availability of anonymous services. #
16 ACCKWA in particular provides support services (counselling) and some transportation for clients, which are not available elsewhere in the community. Furthermore, focus group participants identified that services currently provided in Cambridge are a strong source of information and resources (including needle exchange) for the at risk population in Cambridge. The outreach services have also been well received, with providers indicating that these services are able to reach those who would otherwise not present themselves to the healthcare system. Outreach services were also noted by focus group participants to have been increasingly recognizable by the at risk population. Additional aspects of services working well in Waterloo Region include the provision of in-person services, and the availability of hepatitis C information from a variety of sources. Table 5: Hepatitis C Services in Waterloo Region Questionnaire Results Per cent of Questionnaire Variable Participants Services Used Previously for Hepatitis C Information Public Health 56 Family Doctor 51 Healthcare centre / hospital 44 Outreach worker 37 Internet 36 Family and friends 34 Community agencies 34 Support groups 20 None 16 Other (ACCKWA, detox, school, jail, self study) 6 Difficulties Accessing Hepatitis C Services None 32 Transportation 26 No ID / health card 22 No computer 17 Cost for service 15 Didn't know service was available 14 Hours of operation 13 Too embarrassed 12 Stigma 11 How hepatitis C Information Would Like to be Received Pamphlets 56 Healthcare provider 35 Flyers 34 Internet 34 Outreach worker 32 TV commercials 30 Workshops 28 Posters 26 Peer support 17 Information not wanted 8 Other (ACCKWA, any method, , family) 4 #
17 Barriers to Hepatitis C Services in Waterloo Region Questionnaire respondents indicated which difficulties they encountered when accessing hepatitis C services in Waterloo Region (Table 5). Approximately one third indicated that they had no difficulties accessing services (32 per cent) while a quarter noted transportation as a difficulty (26 per cent). Having no identification or health card (22 per cent) or no computer (17 per cent) accounted for some difficulties with access to hepatitis C services. Focus group providers felt that there were many barriers to accessing hepatitis C services experienced by their clients (Table 6). They noted that not having a treatment site in Cambridge posed significant hurdles, particularly related to transportation. The protocol to access treatment funding for clients from the Ministry of Health and Long- Term Care (MOHLTC) was also barrier. Clients are only able to be treated once in their lifetime for hepatitis C. Various factors influence one s readiness to pursue treatment, including the need to address other health concerns (addiction, mental health, other STIs, etc.). Also, the actual treatment is difficult for the patient as it is lengthy with side effects and therefore not desired by many clients. Focus group participants also noted that clients did not see the urgency to seek treatment without noticing symptoms for hepatitis C. Clients typically are not concerned about their health status until it becomes symptomatic which, in the case of HCV infection, can be many years or decades. Several barriers to the provision of services in Waterloo were identified during the focus groups (Table 6). Participants mentioned a lack of knowledge among potential hepatitis C providers in Waterloo Region on topics related to clinical practice as well as prevention. One participant identified the need to raise the profile of hepatitis C in the community to promote the issue as well as to decrease stigma related to addiction and mental health consequences. A large barrier to providing services was identified as the lack of formal support services for individuals infected, affected or at risk for hepatitis C. Providers mentioned a need for funded support services (counselling, social workers, psychiatrist, psychologists, etc.) to assist hepatitis C clients from prevention, to pre-treatment, during treatment, and after treatment (to prevent relapse). Focus group participants also mentioned inadequate prevention resources in Waterloo Region, particularly targeting sub-populations (youth, endemic populations, etc.). It was also pointed out however, that if prevention services in Waterloo Region do increase and more HCV cases are identified, there would be a need to also increase treatment services in the Region. Managing individuals infected, affected or at risk for hepatitis C was noted as a challenge for providers. Case management is difficult due to the multiple factors that contribute to their health status, resulting in missed medical appointments and non-compliance with treatment. Providers also indicated that the target population can be difficult to reach, noting language/cultural barriers, location, and the fact that the street- and drug-involved population are not within the healthcare system (many do not have family doctors). Lastly, as current hepatitis C services are not coordinated in Waterloo Region, providers stated that they are not aware of referral points to other services or the availability of other skills or resources in the community. Opportunities for Hepatitis C Services in Waterloo Region Questionnaire participants indicated their preferences for receiving information related to hepatitis C (Table 5). Many ideas for future direction of hepatitis C services in Waterloo Region were also discussed during the focus groups (Table 6). Over half (56 per cent) of questionnaire respondents specified that they would like to receive hepatitis C information from pamphlets. Approximately one third responded that they would like information provided by a healthcare #
18 provider (35 per cent), flyers (34 per cent), the internet (34 per cent), an outreach worker (32 per cent), TV commercials (30 per cent), or workshops (28 per cent). Only eight per cent of respondents indicated that they did not want hepatitis C information. Focus group participants identified an abundance of opportunities to improve hepatitis C services in Waterloo Region. Relating to service provision, they saw a need to increase formal support services specifically for hepatitis C clients. The creation of a peer support group for at hepatitis C clients specifically (at risk, current treatment clients, and post-treatment clients) was mentioned by several participants. This support group would comprise of those at risk for HCV due to injection or other drug use, street-involvement, and other risk behaviours, rather than due to blood transfusion. Furthermore, providers indicated the value in expanding treatment services. They mentioned that more physicians in Waterloo Region should specialize in hepatitis C treatment, potentially family practitioners. Outreach services have been well received and focus group participants saw potential in increasing outreach services or even linking with other organizations that currently provide outreach to integrate hepatitis C prevention. The focus group participants stressed that at risk hepatitis C clients, particularly street-involved individuals and IDUs, are comfortable in their own environment, giving credence to outreach as an effective strategy to target those individuals. It was also suggested that prevention services and resources relating to hepatitis C be increased. Targeted education, peer-to-peer education, and integration of prevention methods were identified as potential health promotion approaches. Similarly, advocacy efforts to create supportive policies (e.g. harm reduction housing) can be a technique to decrease stigma as well as to address the broader determinants that contribute to hepatitis C infection. A common theme discussed during focus groups was the value in providing one-stop services for hepatitis C clients. The predominant at risk population for hepatitis C typically presents multiple health concerns beyond HCV infection. Providing multiple services on-site allows for convenience of addressing other health issues, provides anonymity to client in terms of services being sought, and also enables continuity of care practices. Prevention, treatment and support providers and corresponding services were suggested to be housed in one location. For example, offering a general liver clinic was mentioned as one possibility for a one-stop shop model of care. Various working processes can also be put in place to improve hepatitis C service provision in Waterloo Region. Focus group participants stressed the importance of a coordinated regional approach to service provision. Having one regional support coordinator would dedicate time to the management of hepatitis C cases, and also connect providers. They identified a desire to connect with their hepatitis C provider counterparts, thereby enabling them the opportunity to network with one another, be aware of referral points and share resources, skills and knowledge. As previously mentioned, skill and knowledge development of service and care providers can be improved with regards to hepatitis C. Educating potential providers about hepatitis C could increase service capacity and also decrease stigma towards addiction and mental health issues. #
19 Table 6: Focus Group Summary of Hepatitis C Services in Waterloo Region Strengths in Waterloo Region Harm Reduction / Needle Exchange is available, well received and working well Sanguen Health Centre: o Welcoming atmosphere; non-judgemental, well-liked providers o Knowledgeable providers o Wait-list is not lengthy o Ad-hoc provision of support AIDS Committee of Cambridge Kitchener Waterloo & Area (ACCKWA) o Provision of support services and some transport for treatment clients o Referral to other services and information o Provision of services for Cambridge o Non-judgemental staff; anonymous services In-person services o Development of personal rapport with clients o Pre- and post-treatment counselling is effective Outreach o Recognizable by at risk population o Reaches those that otherwise would not seek services Provision of various sources of information Risk profiling works well can identify new clients Barriers to Accessing Services Protocol to access treatment funding from MOHLTC o Qualification only if client has fibrosis or liver function enzyme value 1.5 times normal. HCV is slow progressing and some would like treatment before it worsens. For many addicts, treatment for HCV is one of the last steps to battling addiction. o Treatment funded once only various factors impact client s readiness to successfully proceed Treatment is difficult lengthy, side effects Hepatitis C infection is asymptomatic for years diminishes urgency to seek treatment No treatment site in Cambridge Transportation to medical appointments (especially Cambridge) Lack of support services to encourage treatment Not having a health card (for some facilities) Internet and computer access is limited Stigma associated with addiction / injection drug use o Addiction issues under-funded o Health status of addicts minimized by providers and public Opportunities for Future Direction Central coordination of hepatitis C services o Regional support coordinator (case worker) can refer clients to appropriate services and also connect providers. One-stop: Multiple services on site (general liver clinic, other services) o Allows for: anonymity, continuity of care Networking for hepatitis C providers in Waterloo Region o Awareness of referral points; sharing of resources / knowledge / skills Provision/funding for support services (pre, post, during treatment) o No agency is mandated to provide support services o Support to manage other issues (housing, mental health, transportation, finances, translation) Create peer support group (past and current treatment patients) Provision of transportation to treatment: Volunteer or funded Increase prevention resources/services on hepatitis C specifically o Targeted education for those at risk (youth, cultural, IDU) o Peer to peer strategies are effective o Integrated prevention approach (for risk behaviours) o Education for general public (to decrease stigma) Increase services in Cambridge o No treatment services currently available o ACCKWA should be there 5 days a week (prevention) Professional development for service providers o To increase knowledge about hepatitis C o To be aware of referral points o To decrease stigma associated with at risk populations Expand outreach services o One practical support worker is not enough o Potential to link with other outreach workers o People are comfortable in their own environment Increase treatment providers (only one doctor currently in region) o Increase in family practitioners treatment specialization o Need for treatment will increase if prevention/education increases Advocacy for supportive policies o To address social determinants of health o To decrease stigma Barriers to Provision of Services Services are not coordinated providers not aware of referral points, existing skills/resources No funding for hepatitis C support providers (psychiatrist, psychologist, counsellor, social worker, outreach worker, case worker) Hepatitis C knowledge by providers is inadequate o Staying current with emerging research and practice is challenging Stigma associated with addiction / injection drug use o Health concerns minimized by some providers Harm reduction not supported by all stakeholders Inadequate treatment capacity to meet increasing demand if prevention services are improved Inadequate prevention resources o Targeting at risk youth o To educate healthcare providers o Various languages o On hepatitis C (distinguished from hepatitis A, B) Patient management is challenging o Multiple health factors to consider (addiction, mental health, other health issues) o Missed appointments o Unpredictable demands of services sought o Language/cultural barriers Client population is difficult to reach o Many not in healthcare system o Language/cultural barriers o Location / transportation o Gap in identifying endemic risk populations #
20 #
21 Discussion This situational assessment provided valuable insight into the opportunities for future direction of hepatitis C service and care provision in Waterloo Region. It had been previously identified that gaps exist in this community in terms of hepatitis C services (Steingart 2008) and this report further examines those gaps and provides considerations on how to mitigate them. Questionnaires administered in this study presented a range of participant risk behaviours. It was interesting that only 27 per cent of participants indicated having shared needles, compared to those indicating they shared drug pipes (58 per cent) or gotten a homemade tattoo or piercing (46 per cent). This result could reflect an opportunity to provide education about not sharing any supplies that may not be clean including not only needles but also pipes and body manipulation supplies. Furthermore, this data may reflect the success of the provision of clean needles through the needle exchange programs. Clean smoking/inhalation pipes and supplies for sterile body manipulation (tattoo, piercing) are more difficult to access in Waterloo Region compared to clean needles. In an Ottawa study, Leonard (2008) found that the distribution of safer crack-smoking materials by a needle exchange program contributed to transition to safer methods of drug ingestion and significantly reduced disease-related risk practices. Leonard (2008) mentions that providing the accessibility and availability of safer crack-smoking resources in sufficient quantities can reduce multi-person use, and can enhance the ability of IDUs smoking crack to take control of their own health. They suggest that other needle exchange programs should adopt the practice of distributing glass stems, rubber mouthpieces, brass screens, chopsticks, lip balm and chewing gum to reduce the harms associated with smoking crack (Leonard 2008). The results from the questionnaire yielded some notable findings. Region of Waterloo Public Health was identified as the top source of hepatitis C information for questionnaire participants. It should be noted that this result could be biased due to a large percentage (45 per cent) of the participants having completed the questionnaire at ROWPH. It is also interesting that the top desired sources of hepatitis C information identified by questionnaire respondents were anonymous resources (pamphlets, flyers and internet were three of the top four resources selected by respondents). Anonymity of services being sought was mentioned several times during the focus groups as an effective aspect of offering services to those infected, affected or at risk for hepatitis C. While some anonymous services are desired, it is also important to note that 35 per cent of questionnaire participants indicated that they would like hepatitis C information from a healthcare provider. This result could highlight the importance of individualized and face-to-face service provision. When answering this question, participants may have selected multiple sources of information. It can be speculated that information on certain types of hepatitis C services would like to be received in different ways. For example, anonymous resources (pamphlets, poster, internet etc.) could be desired for prevention services, while treatment information could be favoured to be received from a healthcare professional. Questionnaire results showed that the majority of participants were knowledgeable about hepatitis C, and its transmission. However, the need to increase education among individuals infected, affected or at risk for hepatitis C in Waterloo Region is reflected by results in the questionnaire which indicated the large majority (84 per cent) did not know that hepatitis C has no symptoms. Without knowing that there are no symptoms for hepatitis C for decades, at risk individuals may not see the urgency to seek screening and services, and may unknowingly transmit the infection. Questionnaire results related to knowledge could also be a reflection of sampling limitations. Those that were aware of the study, their risk for hepatitis C and study eligibility may have had more knowledge about hepatitis C at the outset than those that were not reached to participate in the study. Suggestions to increase prevention efforts targeting hepatitis C specifically were concluded in the HCV Strategy Report for Waterloo Region (Steingart 2008), and echoed by focus group participants as part of this situational assessment. Findings from an Australian study support the development of specific education programs regarding treatment for HCV infection for current intravenous drug users (IDUs) (Doab 2005). Another study concluded that #
22 given the gaps in knowledge about hepatitis C among IDUs, it is important that providers make available information about hepatitis C in sites frequented by IDUs including, drug treatment facilities, needle exchange programs and healthcare facilities (Stein 2001). Suggestions were made by focus group participants that resources could be developed or translated into other languages to meet the needs of those infected from endemic countries. Key resources could also be developed to target IDUs and at risk youth in particular. The concern about street-involved youth and their risk for HCV infection has been documented in various Canadian studies (Kerr 2009, Roy 2001, Roy 2003, Miller 2007). Most recently, Kerr (2009) found a high prevalence of injection drug use among street-involved youth and demonstrated its association with various risks and harms, including HCV infection. Previous studies undertaken within North America suggest that many young IDU acquire HCV soon after initiating injecting (Hagan 2007). These findings demonstrate the need to offer effective prevention services targeting street-involved youth specifically. The results from this situational assessment suggest the potential to expand various services related to hepatitis C in Waterloo Region. As mentioned, focus group participants identified the need to increase prevention services targeting hepatitis C specifically (separate from hepatitis A, hepatitis B and HIV). Treatment services were also mentioned to be insufficient if prevention efforts yield more treatment clients. Further discussion will need to occur to explore potential strategies to increase treatment services in Waterloo Region, including strategies to train or attract more primary care providers specializing in hepatitis C. Support services by qualified professionals (social workers, counsellors, psychiatrists, outreach workers, etc.) dedicated to hepatitis C would greatly decrease barriers to access and provision. This was a theme that was repeated at each focus group session. Hepatitis C outreach services in particular were identified as a strong prevention and support service in Waterloo Region, and suggestions were made to expand these services. Thirty-seven per cent of questionnaire participants identified that they had used the services of an outreach worker for hepatitis C information. It is important to note that at the time of data collection, the Hepatitis C Practical Support Outreach Worker from ACCKWA had been providing services for only less than six months. It is possible that respondents may have been referring to other outreach services accessed in Waterloo Region, although less than a handful provide outreach specific for hepatitis C. Although suggestions were made to increase all hepatitis C services Region wide, there was a particular need emphasized for the city of Cambridge, where access to treatment was noted as a large barrier. Transportation was identified as top difficulty by questionnaire respondents, and echoed by focus group providers. In addition, the result that only 38 per cent of questionnaire respondents from Cambridge indicated that they had been tested for hepatitis C (compared to 55 per cent for Kitchener-Waterloo) could indicate different barriers for the services offered or promoted in each area. It should be noted that questionnaire results may have been limited by the relatively small sampling (11 per cent) of participants from Cambridge compared to Kitchener (52 per cent) and Waterloo (17 per cent). A larger sampling from Cambridge may have provided more insight into the difficulties with accessing services in various parts of the region. Several opportunities were discussed during focus groups to improve services for infected, affected and at risk hepatitis C individuals in Waterloo Region. Providers stated that a coordinated strategy where one central point person or organization would manage HCV-positive cases and link clients to services would be effective. This strategy would link clients to providers, but also be a point person for providers to connect with one another to share skills, resources and knowledge. This idea was also described in the 2008 HCV Strategy Report (Steingart 2008). Themes relating to a collaborative regional effort for service delivery were mentioned during focus groups. Mehta (2007) states that comprehensive integrated care strategies that incorporate education, case management and peer support are needed to improve care of HCV-infected individuals. Similarly, Gunn (2005) said that health departments should consider developing collaborative partnerships to provide hepatitis C prevention services. Collaborative hepatitis C service delivery efforts have shown to be effective in the literature. Doab (2005) states that greater collaboration between clinicians and services providing treatment for drugs and alcohol and treatment for HCV infection would improve access to treatment for HCV for injection drug users. The Australian Trial in Acute Hepatitis #
23 C (ATAHC) study suggests that by using a multidisciplinary approach, potential barriers to recruitment and follow-up of IDUs to HCV treatment can be effectively addressed and that this population can be successfully engaged and treated (Nguyen 2007). In addition, a study from New York showed that a comprehensive approach, using multiple strategies across systems and mobilizing multiple sectors (public health, drug treatment programs, correctional settings, healthcare providers, academic institutions, non-governmental organizations, consumers, etc.) can enhance IDUs access to hepatitis C prevention and care (Birkhead 2007). The idea of a one-stop shopping strategy was discussed as an attractive option for providing hepatitis C services by multiple focus group participants. This strategy has yielded some positive results in other communities. The Pender Community Health Centre in Vancouver, British Columbia, developed a model of one-stop shopping whereby the treatment of addiction, HCV and other medical conditions are fully integrated, with the collaboration of nurses, counsellors, addiction specialists, infectious disease specialists, primary care physicians and researchers. Clients interested in receiving treatment were referred to a weekly peer-support group. This clinic received a high uptake of treatment among attendees (51 per cent), with 67 per cent successfully completing treatment (Grebely 2007). Another study noted that those at high risk for STIs, HIV and hepatitis infections could benefit from a one-stop STI clinic that included hepatitis prevention services (Gunn 2000). This allows for prevention and control services to be delivered in an efficient and effective manner (Gunn 2000). OASIS, a community clinic located in California, developed a successful peer-based HCV group that allowed them to engage, educate, test, and treat hepatitis C in large numbers of drug users, the majority of whom have multiple barriers to intervention (Sylvestre 2007). This integrated peer-based approach to intervention can facilitate successful screening and treatment of at risk hepatitis C clients. The creation of a peer support group or network for infected, affected and at risk hepatitis C individuals in Waterloo Region specifically targeting IDUs, drug users and precariously housed individuals was suggested during focus groups. This idea is well supported in academic journals. Nguyen (2000) suggests that the funding of peer workers may be useful in supporting patients on treatment in settings outside the traditional clinic environment. A study with Vancouver street-involved youth demonstrated the importance of social relationships with other drug users within the adoption of injection drug use, highlighting the potential of social interventions to prevent injection initiation (Small 2009). Other epidemiological studies have documented that the majority of drug users are introduced to injection by an individual that is close to them (Crofts 1996, Stenbacka 1990, Varescon 2000). Small (2009) suggests that developing strategies to engage current injectors (peers) who are likely to initiate youth into injection could be a benefit to prevention efforts. Specifically, prevention efforts targeting youth at-risk of injecting should deliver prevention messages through drug user networks in terms meaningful to youth (Roy 2008, Friedman 1992). The peer strategy offers a way to adapt educational material to an appropriate knowledge level. Peer support also improves attendance and encourages cooperation with medical recommendations (Sylvestre 2007). Peer groups are also effective in retaining ethnic minorities (Sylvestre 2007). The groups are a source of information on everything from managing treatment side effects to suggestions about transportation and housing, which is important for an indigent population with limited resources (Sylvestre 2007). Moving forward with improving hepatitis C services in Waterloo Region, a need for skill and knowledge development related to hepatitis C for service and healthcare providers was identified. Several focus group invitees declined participation stating that they did not feel they had enough knowledge about hepatitis C to be a meaningful participant. Concurrently, these providers also acknowledged that HCV infection is a concern for their clients. This issue is similar to findings in other communities where education about hepatitis C for providers was identified as a key strategy to improve HCV services. Doab (2005) mentions that further education programs, both communitybased and for healthcare professionals, are required to improve the understanding of HCV prognosis. Nguyen (2000) also suggests that to successfully treat drug user clients for HCV, a greater understanding of injection drug use is required by healthcare professionals, particularly physicians. Nguyen (2000) goes on to say that some clinicians may lack appropriate training in addiction medicine or effective strategies to manage issues facing IDUs. Consequently, frustration and resentment for both physician and client can act as barriers to successful HCV treatment and follow-up (Nguyen 2000). Similarly, Edlin (2005) concludes that better education of physicians and #
24 healthcare providers about substance use and addiction are needed to improve their understanding of substance misuse and concurrent HCV infection as treatable conditions (Edlin 2005). In Waterloo Region, since the majority of HCV cases are identified through physician ordered screening, physicians should be educated about HCV risk factors and the importance of screening. Finally, considerations for future action related to hepatitis C in Waterloo Region cannot exclude the need to address the broader determinants that subsequently lead to risk-taking behaviour and therefore increased probability of health morbidities. Research has shown that poverty, homelessness, transience, social marginalisation and fear of arrest are potential barriers to effective HCV care (Edlin 2005). Drug treatment clients typically present complex needs (such as poverty, unemployment, criminal justice issues, unstable housing or homelessness) leading to difficulties faced by this client group in accessing treatment and support for health issues (Treloar 2008). For many IDUs, treatment for HCV infection may be a relatively low priority compared with the issues of income, housing, drug access and other health issues (Doab 2005). Despite the complex barriers to health faced by the IDU population, several studies show that IDUs can tolerate and successfully complete HCV treatment (Sylvestre 2005, Backmund 2001, Dalgard 2002, Matthews 2005). Nguyen (2000) suggests strategies to address these and related barriers such as, flexible clinic hours, ready access to a physician, nurse or outreach worker, reminder phone calls, transportation assistance to and from appointments, financial assistance for public transport costs, and appropriate referrals for accommodation, financial and legal issues. These strategies may play a role in improving client attendance and adherence to treatment. Furthermore, efforts to promote population health, reduce poverty, create supportive policies (such as harm reduction) and advocate for social issues should be considered as part of a long-term strategy to combat hepatitis C. In conclusion, there are several services in Waterloo Region available to individuals infected, affected or at risk for hepatitis C. Positive aspects of current services can be leveraged to expand and increase prevention, treatment and support services for hepatitis C. This situational assessment used findings from questionnaires with the target population, focus groups with service and healthcare providers, and peer-reviewed literature to present several opportunities for moving forward with a direction for hepatitis C services in Waterloo Region. Consideration and discussion of next steps for Waterloo Region should be made in consultation with key hepatitis C stakeholders in the community. According to the results of this situational assessment, the application of the aforementioned opportunities for hepatitis C service provision in Waterloo Region has the potential to successfully meet the unique needs of the at risk population. #
25 References Backmund M, Meyer K, Von Zielonka M, Eicehnlaub D. (2001). Treatment of hepatitis C infection in injection drug users. Heptology; 34: Birkhead GS, Klein SJ, Candelas AR, O Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA. (2007). Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: A comprehensive approach. International Journal of Drug Policy; 18: The College of Family Physicians of Canada (CFPC). (2009). Primary Care Management of Chronic Hepatitis C: Professional Desk Reference Retrieved August 26 th, 2009 from Canadian Liver Foundation. (2000). Current status of hepatitis C in Canada. Canadian Journal of Public Health; 91(1). Crofts N, Louie R, Rosenthal D, Jolley D. (1996). The first hit: circumstances surrounding initiation into injection. Addiction; 91(8): Dalgard O, Bjoro K, Hellum K, et al. (2002). Treatment of chronic hepatitis C in injecting drug users: 5 years followup. European Addiction Research; 8: Dinner K, Donaldson T, Potts J, Sirna J, Wong T. (2005). Hepatitis C: a public health perspective and related implications for physicians. Royal College Outlook; 2(3): Doab A, Treloar C, Dore GJ. (2005). Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among injection drug users in Australia. Clinical Infectious Diseases; 40:s Edlin BR, Kresina TF, Raymond DB, Carden MR, Gourevitch MN, Rich JD, Cheever LW, Cargill VA. (2005). Overcoming barriers to prevention, care and treatment of hepatitis C in illicit drug users. Clinical Infectious Diseases; 40(suppl 5): s Friedman SR, Neaigus A, Des Jarlais DC, Sotheran JL, Woods J, Sufian M, Stephenson B, Sterk C. (1992). Social intervention against AIDS among injection drug users. British Journal of the Addictions; 87(3): Grebely J, Genoway K, Khara M, Duncan F, Viljoen M, Elliot D, Raffa JD, DeVlaming S, Conway B. (2007). Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection. International Journal of Drug Policy; 18; Gunn RA, Lee MA, Callahan DB, Gonzales P, Murray PJ, Margolis HS. (2005). Integrating hepatitis, STD, and HIV services into a drug rehabilitation program. American Journal of Preventative Medicine; 29(1): Gunn RA, Murray PJ, Ackers ML, Hardison WGM, Margolis HS. (2000). Screening for chronic hepatitis B and C virus infections in an urban sexually transmitted disease clinic. Sexually Transmitted Diseases; 28(3): Hagan H, Des Jarlais DC, Stern R, Lelutiu-Weinberger C, Scheinmann R, Strauss S, Flom PL. (2007). HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection. International Journal of Drug Policy; 18(5): #
26 Health Canada. (2009). Hepatitis C: It s Your Health. Government of Canada. Kerr T, Marshall BDL, Miller C, Shannon K, Zhang R, Montaner JSG, Wood E. (2009). Injection drug use among street-involved youth in a Canadian setting. BMC Public Health; 9:171. Leonard L, DeRubeis E, Pelude L, Medd E, Birkett N, Seto J. (2008). I inject less as I have easier access to pipes Injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed. International Journal of Drug Policy; 19: Matthews G, Kronbor IJ, Dore GJ. (2005). Treatment for hepatitis C virus infection among current injection drug users in Australia. Clinical Infectious Diseases; 40 (suppl 5): s Mehta SH, Generg BL, Astemborski J, Kavasery R, Kirk GD, Vlahov D, Strathdee SA, Thomas DL. (2008). Limited uptake of hepatitis C treatment among injection drug users. Journal of Community Health; 33: Miller CL, Kerr T, Strathdee SA, Li K, Wood E. (2007). Factors associated with premature mortality among young injection drug users in Vancouver. Harm Reduction Journal; 4:1. Millson P, Leonard L, Remis RS, Strike C, Callacombe L. (2005). Injection drug use, HIV and HCV infection in Ontario: The evidence 1992 to IDU Sitation Report Ministry of Health and Long-Term Care (MOHLTC). (2008). Ontario Public Health Standards Government of Ontario. Nguyen OK, Dore GJ, Kaldor JM, Hellard ME. (2007). Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: Insights from the ATAHC study. International Journal of Drug Policy; 1: Public Health Agency of Canada. (2009). Blood borne Pathogens. Hepatitis C Fact Sheet. Retrieved August 28 th, 2009 from Public Health Agency of Canada. (2007). Epidemiology of Acute Hepatitis C Infection in Canada: Results from the Enhanced Hepatitis Strain Surveillance System (EHSSS). Retrieved August 26 th, 2009 from Public Health Agency of Canada. (2001). Hepatitis C & Injection Drug Use. Retrieved August 28 th, 2009 from Region of Waterloo Public Health. (2006). A Glance at Hepatitis C in Waterloo Region. Public Health Perspectives. Remis, R., Hogg, R., Krahn, M.D., et al. (1998). Estimating the number of blood transfusion recipients infected with hepatitis C virus in Canada, and Report to Health Canada Roy E, Nonn E, Haley N. (2008). Transition to injection drug use among street youth a qualitative analysis. Drug & Alcohol Dependence; 94(1-3): Roy E, Haley N, Leclerc P, Cedras L, Blais L, Boivin JF. (2003). Drug injection among street youths in Montreal: predictors of initiation. Journal of Urban Health; 80(1): Roy E, Haley N, Leclerc P, Boivin JF, Cedras L, Vincelette J. (2001). Risk factors for hepatitis C virus infection among street youths. Canadian Medical Association Journal; 165(5): #
27 Small W, Fast D, Krusi A, Wood E, Kerr T. (2009). Social influences upon injection initiation among street-involved youth in Vancouver Canada: a qualitative study. Sustance Abuse Treatment, Prevention, and Policy; 4:8. Stein MD, Maksad J, Clarke J. (2001). Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment. Drug and Alcohol Dependence; 61: Steingart, Michelle. (2008). Waterloo Region and Wellington-Dufferin-Guelph HCV Strategy. Unpublished. Stenbacka M. (1990). Initiation into intravenous drug abuse. Acta Psychiatrica Scandinavica; 81(5): Strathdee, S., Patrick, D., Currie, S., et al. (1997). Needle exchange is not enough: lessons from Vancouver injecting drug use study. AIDS; 11:F59-F65. Sylvestre DL. (2005). Approaching treatment for hepatitis C virus infection in substance users. Clinical Infectious Diseases; 41: s Sylvestre DL, Zweben JE. (2007). Integrating HCV services for drug users: a model to improve engagement and outcomes. International Journal of Drug Policy; 18: Treloar C, Holt M. (2008). Drug treatment clients readiness for hepatitis C treatment: implications for expanding treatment servicees in drug and alcohol settings. Australian Health Review; 32(3): Varescon I, Vidal-Trecan G, Gagniere B, Christoforov B, Boissonnas A. (2000). Risks incurred by the first intravenous drug injection. Annales de Medecine Interne; 151(suppl B): B5-8. World Health Organization. (2009). Viral Cancers: Hepatitis C. Retrieved August 28 th, 2009 from #
28 #
29 Appendices #
30 #774260
31 Appendix A Questionnaire for individuals infected, affected or at risk for hepatitis C #774260
32 #774260
33 Hepatitis C Community Survey 1. What is hepatitis C? infection of the liver infection of the spleen I don t know infection of the heart blood disorder other 2. How can you get hepatitis C? (Check one or more) public toilets bad food living with someone that has hepatitis C blood to blood tattoos sharing razors and toothbrushes 3. What are some of the signs and symptoms of hepatitis C infection? (Check one or more) tiredness sores shortness of breath yellowing of the skin there are no symptoms 4. Who do you think is most likely to get hepatitis C and why? 5. Have you (Check all that apply): shared needles and supplies for injecting drugs? shared pipes when smoking drugs? had sex for money or drugs? been in jail? lived on the street? ever gotten a homemade tattoo or piercing? blood transfusion before 1992 in Canada? received medical care from outside North America? IF YES, what country 6. Do you know where you can go to get tested for hepatitis C? (Check one or more) family doctor hospital walk in clinic Other #774260
34 7. Have you ever been tested for hepatitis C? YES What was the result? Are you seeking treatment? YES NO NO Why? Do you want to be tested? YES NO 8. Please check any of the following services that you may have used to get information or seek treatment/support about hepatitis C? (Check one or more) Public Health Internet family doctor family & friends support groups outreach workers community agencies healthcare centre/hospital none other (please specify): 9. Have you had any difficulties when using services or getting information? (Check one or more) transportation no ID/health card cost for service stigma/discrimination too embarrassed hours of operation no computer didn t know service was available none other (please specify): 10. How would you like to receive information about hepatitis C? (Check one or more) pamphlets TV commercials Internet posters workshops flyers I don t want any information peer support outreach worker healthcare provider Other 11. What city/municipality do you currently live in? 12. What is your current housing situation? your own place shelter staying with friends and/or family no fixed address (streets) hospital Other (e.g. detox, treatment centre) 13. Age: #774260
35 Sex: Female Male 15. Were you born in Canada? YES NO If not: a) what country were you born in? b) how long have you been living in Canada? THANK YOU FOR YOUR TIME For Research Team use ONLY. Area: Waterloo Kitchener Cambridge Wilmot Wellesley Woolwich North Dumfries Date completed: #774260
36 #774260
37 Appendix B Focus group questions for service providers and healthcare providers #774260
38 #774260
39 Hepatitis C Situational Assessment of Waterloo Region Discussion Guide for Focus Group with Service and Healthcare Providers Objective of Focus Group: To establish the needs of high risk populations in Waterloo Region with reference to hepatitis C education, services and treatment accessibility. * Please Note: The following report is to be used solely as a guide. The facilitator may or may not ask all questions. Target Population 1. The project is intended to target high risk groups for hepatitis C such as people who inject drugs, sex workers, homeless and precariously housed individuals, street involved youth, immigrant populations from endemic countries and people who were formally incarcerated. Are there other people who may be infected, affected, or at high risk for hepatitis C in Waterloo Region who aren t included on this list? 2. How well do you believe people who are at high risk for hepatitis C understand their risk? Do they understand how they may develop/transmit hepatitis C? Do they understand what they can do to prevent hepatitis C? Hepatitis C Prevention, Treatment and Support Services 3. What types of hepatitis C prevention and treatment services are currently available in Waterloo Region and how well do you think they are working? 4. What other types of prevention and treatment services do people at high risk for hepatitis C in the Waterloo Region need? 5. Which aspects of the programs or services available for people at high risk for hepatitis C do your clients find helpful? Which aspects are meeting their needs? 6. Which aspects of the programs or services available for people at high risk for hepatitis C do your clients find least helpful? Which aspects are not meeting their needs? Ethno-cultural considerations? 7. What service model(s) would best fit the needs of people at high risk for hepatitis C in Waterloo Region with regards to prevention and/or treatment? For example, home visits, street based services, mosaic approach, one-stop-shop approach #774260
40 8. As a healthcare or service provider, is there anything that limits your ability to meet the needs of your clients? What general challenges do you face as healthcare providers? Are there related areas that you feel are out of your control to help with? 9. What could be done to improve hepatitis C prevention and treatment services for high risk populations? 10. Any other comments, questions, concerns, or feedback? #774260
HEPATITIS C. The Facts. Get Tested. Get Cured! Health
HEPATITIS C The Facts Get Tested. Get Cured! Health EVEN IF YOU FEEL HEALTHY, HEPATITIS C MAY BE DAMAGING YOUR LIVER. Your liver keeps you healthy in many ways, such as by removing toxins from your blood
Hepatitis C. Screening, Diagnosis and Linkage to Care
Hepatitis C Screening, Diagnosis and Linkage to Care Diagnosis If your hepatitis C antibody test is reactive, a second test will be needed to diagnose and determine if you are currently infected. Screening
Information about hepatitis C for patients and carers
Information about hepatitis C for patients and carers What is hepatitis C? Hepatitis C is an illness caused by a virus which can be passed through blood from one person to another. It mainly affects the
THE A, B, C S OF HEPATITIS. Matt Eidem, M.D. Digestive Health Associates of Texas 1600 Coit Road Suite #301 Plano, Texas 75075 (972) 867-0019
THE A, B, C S OF HEPATITIS Matt Eidem, M.D. Digestive Health Associates of Texas 1600 Coit Road Suite #301 Plano, Texas 75075 (972) 867-0019 WHAT IS HEPATITIS? Hepatitis means inflammation of the liver
BASIC INFORMATION ABOUT HIV, HEPATITIS B and C, and TUBERCULOSIS Adapted from the CDC
BASIC INFORMATION ABOUT HIV, HEPATITIS B and C, and TUBERCULOSIS Adapted from the CDC HIV What are HIV and AIDS? HIV stands for Human Immunodeficiency Virus. This is the virus that causes AIDS. HIV is
Hepatitis C Infections in Oregon September 2014
Public Health Division Hepatitis C Infections in Oregon September 214 Chronic HCV in Oregon Since 25, when positive laboratory results for HCV infection became reportable in Oregon, 47,252 persons with
Patient Information Sheet
Healthcare Worker exposure to a patient s blood What is a healthcare worker exposure? Patient Information Sheet Occasionally, health care workers come into contact with the blood or body fluids of their
Beginner's guide to Hepatitis C testing and immunisation against hepatitis A+B in general practice
Beginner's guide to Hepatitis C testing and immunisation against hepatitis A+B in general practice Dr Chris Ford GP & SMMGP Clinical Lead Kate Halliday Telford & Wrekin Shared Care Coordinator Aims Discuss:
www.hepinfo.ie Are you Hep C aware? awareness information support prevention To find out more visit
Are you Hep C aware? awareness information support prevention To find out more visit www.hepinfo.ie What is Hepatitis C? Hepatitis C is a viral infection that affects the liver, causing it to become inflamed
HIV/AIDS: General Information & Testing in the Emergency Department
What Is HIV? HIV/AIDS: General Information & Testing in the Emergency Department HIV is the common name for the Human Immunodeficiency Virus. HIV is a retrovirus. This means it can enter the body s own
The Hepatitis B virus (HBV)
The Hepatitis B virus (HBV) There are 400 million people in the world who live with chronic hepatitis B, including France. Most people don t even know they are infected. But there are several important
Recommendations for the Identification of Chronic Hepatitis C virus infection Among Persons Born During 1945-1965
Recommendations for the Identification of Chronic Hepatitis C virus infection Among Persons Born During 1945-1965 MMWR August 17, 2012 Prepared by : The National Viral Hepatitis Technical Assistance Center
english facts about hepatitis A, B and C
english facts about hepatitis A, B and C What is hepatitis? Hepatitis means inflammation of the liver. Many viruses can cause liver inflammation, including the hepatitis A, B and C viruses. Some people
Sexual Health and Sexually Transmitted Infections Prevention and Control Protocol, 2013 (Revised)
Sexual Health and Sexually Transmitted Infections Prevention and Control Protocol, 2013 (Revised) Preamble The Ontario Public Health Standards (OPHS) are published by the Minister of Health and Long- Term
Viral Hepatitis A, B, and C
Viral Hepatitis A, B, and C What is Hepatitis? Hepatitis means inflammation of the liver Elizabeth A. Bancroft, MD, SM Acute Communicable Disease Control County of Los Angeles Department of Public Health
HIV/AIDS Tool Kit. B. HIV/AIDS Questionnaire for Health Care Providers and Staff
8 HIV/AIDS Tool Kit B. HIV/AIDS Questionnaire for Health Care Providers and Staff FOR STAFF USE ONLY: SURVEY ID # HIV/AIDS KAP Questionnaire for Health Care Providers and Staff Introduction The goal of
Preface. TTY: (888) 232-6348 or [email protected]. Hepatitis C Counseling and Testing, contact: 800-CDC-INFO (800-232-4636)
Preface The purpose of this CDC Hepatitis C Counseling and Testing manual is to provide guidance for hepatitis C counseling and testing of individuals born during 1945 1965. The guide was used in draft
Part 5: Harm Reduction
Part 5: Harm Reduction Introduction Harm reduction principles are foundational to public health and community based programming intended to meet the needs of injection drug users (1). Harm reduction: Is
Commonly Asked Questions About Chronic Hepatitis C
Commonly Asked Questions About Chronic Hepatitis C From the American College of Gastroenterology 1. How common is the hepatitis C virus? The hepatitis C virus is the most common cause of chronic viral
GENERAL INFORMATION. Hepatitis B Foundation - Korean Chapter Pg. 3 www.hepb.org
GENERAL INFORMATION What is hepatitis B? Hepatitis B is the world's most common liver infection that can lead to cirrhosis and liver cancer. It is caused by the hepatitis B virus (HBV), which attacks and
12/2/2015 HEPATITIS B AND HEPATITIS C BLOOD EXPOSURE OBJECTIVES VIRAL HEPATITIS
HEPATITIS B AND HEPATITIS C BLOOD EXPOSURE DISEASE 101 ONLINE CONFERENCE SARAH WENINGER, MPH VIRAL HEPATITIS.STD.HIV PREVENTION COORDINATOR DECEMBER 3, 2015 OBJECTIVES Describe the populations that should
National Health Burden of CLD in Italy
National Health Burden of CLD in Italy 11,000 deaths due to liver cirrhosis or HCC in 2006 Direct costs for the National Health System for treating CLD patients: 420 M / year for hospital care 164 M /
GROUND UP. Insite was specifically designed to be accessible to
Vancouver s Supervised Injection Site s Role in Accessing Treatment and Care GROUND UP Canada has long been regarded as a global leader in health care delivery and innovation. Since September 2003, Insite,
Learning about Hepatitis C and Chronic Kidney Disease
Learning about Hepatitis C and Chronic Kidney Disease Hepatitis C and Chronic Kidney Disease If you have chronic kidney disease (CKD), you want to learn all you can about your disease and what you can
Briefing Note: Hepatitis B & Hepatitis C. Summary:
Briefing Note: Hepatitis B & Hepatitis C Summary: In Canada, hepatitis B and hepatitis C infections remain serious public health concerns due to high prevalence rates, high health care expenditures and
Appendix 3 Exposure Incident Report Form
Appendix 3 Exposure Incident Report Form January, 2015 Page 1 of 6 Please see the following pages for the Exposure Incident Report Form. Guidelines for the Management of Exposure to Blood and Body Fluids
POST EXPOSURE PROPHYLAXI S
Departments of Infectious Diseases & Emergency Medicine POST EXPOSURE PROPHYLAXI S QUI CK GUI DE FOR EMERGENCY DEPT Adapted from Irish National PEP Guidelines and St James s Hospital GUIDE Clinic/Emergency
EPIDEMIOLOGY OF HEPATITIS B IN IRELAND
EPIDEMIOLOGY OF HEPATITIS B IN IRELAND Table of Contents Acknowledgements 3 Summary 4 Introduction 5 Case Definitions 6 Materials and Methods 7 Results 8 Discussion 11 References 12 Epidemiology of Hepatitis
CANCER OF THE LIVER HEPATOCELLULAR CARCINOMA
CANCER OF THE LIVER HEPATOCELLULAR CARCINOMA WHAT IS CANCER OF THE LIVER? Hepatocellular carcinoma is the most common form and it comes from the main type of liver cell, the hepatocyte. About 3 out 4
Exposure. What Healthcare Personnel Need to Know
Information from the Centers for Disease Control and Prevention National Center for Infectious Diseases Divison of Healthcare Quality Promotion and Division of Viral Hepatitis For additional brochures
1.How did I get Hepatitis C?
1.How did I get Hepatitis C? Sharing needles and syringes ( iv drug use ) or using contaminated straws to snort cocaine Reused needles or medications in a health care setting- (LV endoscopy outbreak, glucometers
Frequently Asked Questions (FAQs)
Frequently Asked Questions (FAQs) Research Rationale 1. What does PrEP stand for? There is scientific evidence that antiretroviral (anti-hiv) medications may be able to play an important role in reducing
Stigma and Discrimination
Stigma and Discrimination T he Network of Associations for Harm Reduction (NAHR) aims to reduce HIV/AIDS Stigma and Discrimination towards Most at Risk Populations (MARPs) and People Living with HIV/AIDS
Strengthening the HCV Continuum of Care
Strengthening the HCV Continuum of Care Fabienne Laraque, MD, MPH, Medical Director Viral Hepatitis Surveillance, Prevention and Control Bureau of Communicable Diseases Control, NYC DOHMH March 18, 2014
Guidelines for Viral Hepatitis CTR Services
Guidelines for Viral Hepatitis CTR Services During the 2007 North Dakota Legislative Assembly, legislation that called for the creation of a viral hepatitis program was introduced and approved. The North
Newly Diagnosed: HEPATITIS C. American Liver Foundation Support Guide
Newly Diagnosed: HEPATITIS C American Liver Foundation Support Guide T he American Liver Foundation's mission is to facilitate, advocate, and promote education, support, and research for the prevention,
HIV and AIDS in Bangladesh
HIV and AIDS in Bangladesh BACKGROUND The first case of HIV/AIDS in Bangladesh was detected in 1989. Since then 1495 cases of HIV/AIDS have been reported (as of December 2008). However UNAIDS estimates
Viral hepatitis. Report by the Secretariat
SIXTY-THIRD WORLD HEALTH ASSEMBLY A63/15 Provisional agenda item 11.12 25 March 2010 Viral hepatitis Report by the Secretariat THE DISEASES AND BURDEN 1. The group of viruses (hepatitis A, B, C, D and
3/25/2014. April 3, 2014. Dennison MM, et al. Ann Intern Med. 2014;160:293 300.
April 3, 2014 3.6 million persons ever infected; 2.7 million chronic infections 1 Up to 75% unaware of status Transmitted through percutaneous exposure to infected blood Injection drug use (IDU) is the
NOTICE OF PUBLIC HEARING REGARDING PROPOSED CHANGES IN HEALTH CARE SERVICES PROVIDED BY FRESNO COUNTY
NOTICE IS HEREBY GIVEN that a public hearing will commence on Tuesday, September 23, 2008, at 9:00 a.m. (subject to continuance on that date of the hearing) at the Fresno County Board of Supervisors Chambers,
A P P E N D I X SAMPLE FORMS
A P P E N D I X A SAMPLE FORMS Authorization for Disclosure Consent for HBV/HCV Antigens, HIV Antibody Documentation of Staff Education Employees Eligible for Hepatitis-B Vaccination Hepatitis-A Consent
Course Description. SEMESTER I Fundamental Concepts of Substance Abuse MODULE OBJECTIVES
Course Description SEMESTER I Fundamental Concepts of Substance Abuse MODULE OBJECTIVES At the end of this course participants will be able to: Define and distinguish between substance use, abuse and dependence
FAQs HIV & AIDS. What is HIV? A virus that reduces the effectiveness of your immune system, meaning you are less protected against disease.
HIV & AIDS What is HIV? A virus that reduces the effectiveness of your immune system, meaning you are less protected against disease. What does HIV stand for? Human Immunodeficiency Virus Where did HIV
STOP TELLING US NOT TO SHARE Participatory project design
STOP TELLING US NOT TO SHARE Participatory project design Increasing access to clean injecting in Myitkyina township 3 Diseases Fund annual review 16 December 2010 Médecins du Monde In Myanmar French medical
When an occupational exposure occurs, the source patient should be evaluated for both hepatitis B and hepatitis C. (AII)
XI. OCCUPATIONAL EXPOSURES TO HEPATITIS B AND C RECOMMENDATION: When an occupational exposure occurs, the source patient should be evaluated for both hepatitis B and hepatitis C. (AII) The risk of transmission
PROGRAM TITLE: Youth Health and Wellness Clinic. Michigan. Name of Health Department: Grand Traverse County Health Department,
PROGRAM TITLE: Youth Health and Wellness Clinic Name of Health Department: Grand Traverse County Health Department, Michigan Short Description: The Grand Traverse County Health Department s Youth Health
What you should. know
H e p a t i t i s C What you should know Table of Contents Hepatitis C: a part of life for many people.......4 What is hepatitis C?.......................6 What does my liver do?....................8 How
environics research group
environics research group FINAL REPORT Canadian Adult National Immunization Coverage (Adult NICS) Survey 2006 Prepared for: Public Health Agency of Canada (PHAC) November 2006 HC POR # POR-05-75 336 MacLaren
Bloodborne Pathogens (HIV, HBV, and HCV) Exposure Management
Bloodborne Pathogens Exposure Policy and Procedures Employees of the State of South Dakota Department of Health Bloodborne Pathogens (HIV, HBV, and HCV) Exposure Management PEP Hotline 1-888-448-4911 DOH
The Epidemiology of Hepatitis A, B, and C
The Epidemiology of Hepatitis A, B, and C Jamie Berkes M.D. University of Illinois at Chicago [email protected] Epidemiology: Definitions The study of the incidence and prevalence of diseases in large populations
Key Challenges and Unmet Needs in Bipolar Disorder
Key Challenges and Unmet Needs in Bipolar Disorder Bridging the Gap Between Healthcare Professionals and Patients A Pilot Malaysian Study March and April 2010 WHAT THE REPORT WILL COVER Executive Summary
Legal Issues for People with HIV
Legal Issues for People with HIV Duke Legal Project Box 90360 Durham, NC 27708-0360 (919) 613-7169 (888) 600-7274 Duke Legal Project is a clinical legal education program of Duke Law School. Legal Representation
Family Services Of Greater Vancouver. Serving a High Needs Population in a Harm Reduction model. Jennifer Hanrahan Senior Manager of Youth Services
Family Services Of Greater Vancouver Serving a High Needs Population in a Harm Reduction model Jennifer Hanrahan Senior Manager of Youth Services Serving a High Needs Population in a Harm Reduction Model
Bloodborne Pathogens. San Diego Unified School District Nursing & Wellness Program August 2013
Bloodborne Pathogens San Diego Unified School District Nursing & Wellness Program August 2013 Why Another In-service?? Cal/OSHA mandates that employees with occupational exposure are informed at the time
Injection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results
Injection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results David W. Forrest, Ph.D. Marlene LaLota, M.P.H. John-Mark Schacht Gabriel A. Cardenas, M.P.H. Lisa Metsch, Ph.D. National HIV Behavioral
INFORMATION ABOUT HEPATITIS C
INFORMATION ABOUT HEPATITIS C PATIENT BOOKLET Index 1 About Hepatitis C About Hepatitis C Page 1 Hepatitis C Transmission Page 3 Hepatitis C Disease Progression Page 4 Hepatitis C Diagnosis and Treatment
New Brunswick Health Indicators
New Brunswick Health Indicators Issue 8, July 2013 A population health bulletin published by the Office of the Chief Medical Officer of Health Youth Sexual Health Sexual health is an important aspect of
OCCUPATIONAL HEALTH, DISABILITY AND LEAVE SECTOR MEASURES TO MINIMIZE EXPOSURE TO BLOODBORNE PATHOGENS AND POST-EXPOSURE PROPHYLAXIS POLICY
UNIVERSITY OF OTTAWA OCCUPATIONAL HEALTH, DISABILITY AND LEAVE SECTOR MEASURES TO MINIMIZE EXPOSURE TO BLOODBORNE PATHOGENS AND POST-EXPOSURE PROPHYLAXIS POLICY Prepared by the Occupational Health, Disability
Safe Tattooing How is it done? Things to remember before getting a tattoo: What are the risks? Hepatitis B Hepatitis C: HIV/AIDS:
Safe Tattooing How is it done? A tattoo consists of pigmentation that is inserted into the second layer of the skin. A vertical vibrating instrument is used to inject the pigment 50 to 3000 times per minute.
Pediatric Latent TB Diagnosis and Treatment
Date Updated: April 2015 Guidelines Reviewed: 1. CDC Latent TB Guidelines 2. Harborview Pediatric Clinic Latent TB Management, 2010 3. Pediatric Associates Latent TB Guidelines, 2013 4. Seattle Children
AN OVERVIEW OF PROGRAMS FOR PEOPLE WHO INJECT DRUGS
AN OVERVIEW OF PROGRAMS FOR PEOPLE WHO INJECT DRUGS Helgar Musyoki MARPs and Vulnerable Groups Program National AIDs/STI Control Programme November 2012 Background Injection of heroin in Kenya reportedly
SIXTY-SEVENTH WORLD HEALTH ASSEMBLY. Agenda item 12.3 24 May 2014. Hepatitis
SIXTY-SEVENTH WORLD HEALTH ASSEMBLY WHA67.6 Agenda item 12.3 24 May 2014 Hepatitis The Sixty-seventh World Health Assembly, Having considered the report on hepatitis; 1 Reaffirming resolution WHA63.18,
UNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON HIV/AIDS. Country Progress Report 2008. Sweden
UNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON HIV/AIDS Country Progress Report 2008 Sweden ABBREVIATIONS...3 ACKNOWLEDGEMENTS...4 STATUS AT A GLANCE...1 NATIONAL INDICATOR DATA... 2 OVERVIEW OF THE
DC NEX. District of Columbia Needle Exchange Programs. Policies and Procedures Manual
District of Columbia Needle Exchange Programs Policies and Procedures Manual May 2009 This manual was assembled by the: Government of the District of Columbia HIV/AIDS Administration Prevention and Intervention
Tuberculosis Management of People Knowingly Placing Others at Risk of Infection
Policy Directive Ministry of Health, NSW 73 Miller Street North Sydney NSW 2060 Locked Mail Bag 961 North Sydney NSW 2059 Telephone (02) 9391 9000 Fax (02) 9391 9101 http://www.health.nsw.gov.au/policies/
Hepatitis C Virus Infection: Prevalence Report, 2003 Data Source: Minnesota Department of Health HCV Surveillance System
Hepatitis C Virus Infection: Prevalence Report, 2003 Data Source: Minnesota Department of Health HCV Surveillance System P.O. Box 9441 Minneapolis, MN 55440-9441 612-676-5414, 1-877-676-5414 www.health.state.mn.us/immunize
Guidelines for Managing Exposures to Blood Borne Pathogens
Guidelines for Managing Exposures to Blood Borne Pathogens Revised May 2010 Table of Contents Introduction 1 Exposure to Blood/Body Fluids 2 A. Initial Management Guidelines I. General Measures 2 II. Evaluate
Managing Bloodborne Pathogens Exposures
Managing Bloodborne Pathogens Exposures House Staff Orientation 2015 Phillip F. Bressoud, MD, FACP Associate Professor of Medicine and Executive Director Campus Health Services University of Louisville
PLUS MAY EQUAL. Flu-Like Symptoms SORE THROAT, SWOLLEN GLANDS, FEVER, JOINT AND MUSCLE ACHES
What is acute HIV infection? Acute HIV infection is the very early stage of infection with HIV (human immunodeficiency virus), the virus that causes AIDS. This is also called primary HIV infection. Acute
WHAT YOU NEED TO KNOW ABOUT HEPATITIS C: A GUIDE FOR PEOPLE WITH HIV INFECTION
WHAT YOU NEED TO KNOW ABOUT HEPATITIS C: A GUIDE FOR PEOPLE WITH HIV INFECTION Did you know that in the United States, at least 1 in 4 people with HIV is also infected with hepatitis C? Hepatitis C is
Like cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive.
Heroin Introduction Heroin is a powerful drug that affects the brain. People who use it can form a strong addiction. Addiction is when a drug user can t stop taking a drug, even when he or she wants to.
Public Health Services
Public Health Services FUNCTION The functions of the Public Health Services programs are to protect and promote the health and safety of County residents. This is accomplished by monitoring health status
Hepatitis C Virus Infection in Massachusetts: A tale of two epidemics
Hepatitis C Virus Infection in Massachusetts: A tale of two epidemics Daniel Church, MPH Massachusetts Department of Public Health Bureau of Infectious Disease 1 Goals of presentation Provide an overview
REPUBLIC OF KENYA MINISTRY OF HEALTH NATIONAL POLICY ON INJECTION SAFETY AND MEDICAL WASTE MANAGEMENT
REPUBLIC OF KENYA MINISTRY OF HEALTH NATIONAL POLICY ON INJECTION SAFETY AND MEDICAL WASTE MANAGEMENT MINISTRY OF HEALTH NATIONAL POLICY INJECTION SAFETY AND MEDICAL WASTE MANAGEMENT FEBRUARY 2007 National
CASE STUDY: CHICAGO HEALTH OUTREACH Chicago, Illinois
CASE STUDY: CHICAGO HEALTH OUTREACH Chicago, Illinois This project was funded by a grant from the Health Resources and Services Administration, U.S. Department of Health and Human Services, grant #4H97HA001580201.
Brantford Native Housing Residential Support/ Addiction Treatment Program
Brantford Native Housing Residential Support/ Addiction Treatment Program Application Package Ojistoh House or Karahkwa House 318 Colborne Street East Brantford, ON N3S 3M9 (519) 753-5408 x 235 T (519)
Xs4 t5 Pauktuutit wkw5 x3nw5 vnbu INUIT WOMEN OF CANADA. Frequently Asked Questions. About Hepatitis C Q&A
Xs4 t5 Pauktuutit wkw5 x3nw5 vnbu INUIT WOMEN OF CANADA Frequently Asked Questions About Hepatitis C Q&A Design EarthLore Communications Photos: front cover, back cover and pages 11 and 13 in question
drug treatment in england: the road to recovery
The use of illegal drugs in England is declining; people who need help to overcome drug dependency are getting it quicker; and more are completing their treatment and recovering drug treatment in ENGlaND:
Hospitalizations for Hepatitis A, B, and C, Active Component, U.S. Armed Forces, 1991-2011
Hospitalizations for Hepatitis A, B, and C, Active Component, U.S. Armed Forces, 1991-2011 lthough genetically quite distinct from one another, hepatitis viruses A, B, and C all cause inflammatory liver
CHAPTER 10. 1. Section 3 of P.L.2013, c.46 (C.24:6J-3) is amended to read as follows:
CHAPTER 10 AN ACT concerning overdose prevention and sterile syringe access programs, and amending P.L.2006, c.99 and P.L.2013, c.46. BE IT ENACTED by the Senate and General Assembly of the State of New
Depression Support Resources: Telephonic/Care Management Follow-up
Depression Support Resources: Telephonic/Care Management Follow-up Depression Support Resources: Telephonic/Care Management Follow-up Primary Care Toolkit September 2015 Page 29 Role of the Phone Clinician
Tuberculosis Prevention and Control Protocol, 2008
Tuberculosis Prevention and Control Protocol, 2008 Preamble The Ontario Public Health Standards (OPHS) are published by the Minister of Health and Long- Term Care under the authority of the Health Protection
Planning for an Influenza Pandemic
Overview It is unlikely that a new pandemic influenza strain will first emerge within Elgin County. The World Health Organization (WHO) uses a series of six phases, as outlined below, of pandemic alert
